Figure 1. Structure of two poxtA-carrying plasmids in E

Slides:

Advertisements

Similar presentations

Figure 1. Ten chemotherapeutic drugs induce the bacterial SOS response

Advertisements

Figure 1. Direct evidence for the acquisition and demise of Tn6330 by DNA sequence alignment. (a) Comparison between ... Figure 1. Direct evidence for.

Figure 1. Comparative chromosome map of the CP-hvKP strain (NUHL30457) and 10 other hvKP strains (1158, CG43, HK787, ... Figure 1. Comparative chromosome.

Figure 1. Distribution of ABCB1 SNVs and haplotypes.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

(A) Calcinosis cutis on the extensor side of the left upper arm ...

Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1. Colistin MIC distribution for the 153 colistin-resistant E

Figure 1. Variation in population size of the donor strain HN-1 and E

Figure 1 Phases of the research. Author’s own work.

Figure 1. Structure of resistance islands containing dfrA35 in IncC plasmids. (a) pEc158 resistance island and (b) ... Figure 1. Structure of resistance.

Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. Physician rankings from 0 to 100 in the odds of prescribing an antibiotic. The y-axis represents the null ... Figure 1. Physician rankings from.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

AHA: American Heart Association; ALT: ...

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Figure 1. SpeI-PFGE dendrogram comparing P

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

RCTs: randomized controlled ...

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Figure 1. Uptake of relebactam into human OAT1, OAT3 and OCT2 stably transfected cells. Time-dependent uptake of ... Figure 1. Uptake of relebactam into.

Take home figure The protective role of CNP/NPR-B/NPRC.

Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.

x-axis, post-partum days. Closed ...

Fig. 1 HRCT of the chest, showing centrilobular nodules (white arrows in A and B), a large subpleural nodule (black ... Fig. 1 HRCT of the chest, showing.

Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Figure 1. Mean log10 cfu/mL versus time profile for each individual drug at 4× MIC against the four VRE ... Figure 1. Mean log10 cfu/mL versus.

Fig. 1 Flow chart for selection of study subjects

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Figure 1. Susceptibility of all P

Figure 1. (a) Geographical representation of sample collection area

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.

Figure 1. Sequence comparison of plasmid pG38 (GenBank accession no

Figure 1 (a) Genetic backbone of pECPB39 (MG886287) and pKP13a (CP003996) plasmids. In pECPB39, the ΔproP-mcr-5.3-chrB ... Figure 1 (a) Genetic backbone.

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.

Figure 1. Outer membrane protein profiling of parental strain KJΔDEFΔ5 and its derivative fluoroquinolone-resistant ... Figure 1. Outer membrane protein.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Colony morphology of an A. fumigatus non-WT strain and an A

Figure 1. The unique structures of the SCCmec type II element identified in ORSL strain CGMH-SL Figure 1. The unique structures of the SCCmec type.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. Observed mean (SD) micafungin plasma concentrations.

Figure 2. (a) Geometric mean (%CV) tenofovir diphosphate concentrations (TFV-DP in fmol/punch) in dried blood spot ... Figure 2. (a) Geometric mean (%CV)

Fig. 1 A network representation of top 100 co-occurring terms

Figure 1. Genetic context of blaNDM-21 on pNDM21_020023

Fig. 1 Statistics of the main characters’ dialogues.

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.

Figure 1. CCG and practice decile and extreme percentile (1–9, 91–99) time trends, 2011–17. This figure appears in ... Figure 1. CCG and practice decile.

Figure 1 Strategies for reconciling protection and participation.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Table 2. Mean noise level results for hand dryers in dBA

Figure 1. Kaplan–Meier curves showing the impact of the different pretreatment HIV-1 drug resistance categories on the ... Figure 1. Kaplan–Meier curves.

Presentation transcript:

Figure 1. Structure of two poxtA-carrying plasmids in E Figure 1. Structure of two poxtA-carrying plasmids in E. faecalis in this study. (a) Structure of the poxtA- and ... Figure 1. Structure of two poxtA-carrying plasmids in E. faecalis in this study. (a) Structure of the poxtA- and optrA-co-carrying plasmid pE035. The positions of three mobile elements (MGE<sub>1</sub>, MGE<sub>2</sub> and MGE<sub>3</sub>) are indicated by bold vertical lines and arrows outside the plasmid. (b) Structure of the poxtA-carrying plasmid pE076. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) J Antimicrob Chemother, dkz109, https://doi.org/10.1093/jac/dkz109 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. Structure of UCS located on plasmid pE035 in E Figure 2. Structure of UCS located on plasmid pE035 in E. faecalis in this study. (a) Structure of UCS located on ... Figure 2. Structure of UCS located on plasmid pE035 in E. faecalis in this study. (a) Structure of UCS located on plasmid pE035 with attL and attR sites located on both sides, compared with the sequences on plasmid ARO1/DG. (b) Remaining structure after the excision of UCS on plasmid pE035. (c) Circular form of UCS. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) J Antimicrob Chemother, dkz109, https://doi.org/10.1093/jac/dkz109 The content of this slide may be subject to copyright: please see the slide notes for details.